Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory Lymphoma

This study has been completed.

Study NCT00061672 Information provided by Abbott

First Received: June 2, 2003 Last Updated: August 13, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given